Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeyakanthan Jeyaraman

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Journal of Molecular Graphics & Modelling|September 27, 2016
A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation studySanjay K Choubey, Jeyakanthan Jeyaraman
Combinatorial Chemistry & High Throughput Screening|May 19, 2023
HTNpedia: A Knowledge Base for Hypertension ResearchLakshmanan Loganathan, Jeyakanthan Jeyaraman, Karthikeyan Muthusamy
Journal of Molecular Graphics & Modelling|March 25, 2025
Exploring phytochemicals and marine natural products as alternative therapeutic agents targeting phosphotransacetylase (PTA) in Mycobacterium tuberculosis: An underexplored drug targetSneha Subramaniyan, Manikandan Jayaraman, Jeyakanthan Jeyaraman
Expert Review of Medical Devices|March 20, 2026
Advancing digital mental healthcare: the role of artificial intelligence and natural language processing in powering medical chatbots for future healthcare interventionsMaharaja Muthuvairam Subbulakshmi, Manikandan Jayaraman, Jeyakanthan Jeyaraman
Bioinformation|August 16, 2018
Insights from the Molecular modeling, docking analysis of illicit drugs and Bomb Compounds with Honey Bee Odorant Binding Proteins (OBPs)Kulanthaivel Langeswaran, Jeyakanthan Jeyaraman, Richard Mariadasse, et al.
Archives of Biochemistry and Biophysics|September 26, 2024
Harnessing marine natural products to inhibit PAD4 triple mutant: A structure-based virtual screening approach for rheumatoid arthritis therapySanthiya Panchalingam, Manikandan Jayaraman, Jeyakanthan Jeyaraman, et al.
Computational Biology and Chemistry|December 12, 2023
Computational insights into potential marine natural products as selective inhibitors of Mycobacterium tuberculosis InhA: A structure-based virtual screening studyManikandan Jayaraman, Vijayakumar Gosu, Rajalakshmi Kumar, et al.
Computers in Biology and Medicine|January 17, 2026
Machine learning guided structural dynamics identifies translation elongation factor 1 (EEF1A1) as an immunological biomarker and marine natural products as therapeutic leads for rheumatoid arthritis with major depressive disorderSanthiya Panchalingam, Govindaraju Kasivelu, Manikandan Jayaraman, et al.
Computational Biology and Chemistry|April 14, 2024
Mechanistic insights into the conformational changes and alterations in residual communications due to the mutations in the pncA Gene of Mycobacterium tuberculosis: A computational perspective for effective therapeutic solutionsManikandan Jayaraman, Rajalakshmi Kumar, Santhiya Panchalingam, et al.
Computational Biology and Chemistry|September 6, 2023
Multilayer precision-based screening of potential inhibitors targeting Mycobacterium tuberculosis acetate kinase using in silico approachesSneha Subramaniyan, Hemavathy Nagarajan, Umashankar Vetrivel, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Journal of Molecular Graphics & Modelling|September 27, 2016
A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D- QSAR analysis, molecular docking, density functional and molecular dynamics simulation studySanjay K Choubey, Jeyakanthan Jeyaraman
Combinatorial Chemistry & High Throughput Screening|May 19, 2023
HTNpedia: A Knowledge Base for Hypertension ResearchLakshmanan Loganathan, Jeyakanthan Jeyaraman, Karthikeyan Muthusamy
Journal of Molecular Graphics & Modelling|March 25, 2025
Exploring phytochemicals and marine natural products as alternative therapeutic agents targeting phosphotransacetylase (PTA) in Mycobacterium tuberculosis: An underexplored drug targetSneha Subramaniyan, Manikandan Jayaraman, Jeyakanthan Jeyaraman
Expert Review of Medical Devices|March 20, 2026
Advancing digital mental healthcare: the role of artificial intelligence and natural language processing in powering medical chatbots for future healthcare interventionsMaharaja Muthuvairam Subbulakshmi, Manikandan Jayaraman, Jeyakanthan Jeyaraman
Bioinformation|August 16, 2018
Insights from the Molecular modeling, docking analysis of illicit drugs and Bomb Compounds with Honey Bee Odorant Binding Proteins (OBPs)Kulanthaivel Langeswaran, Jeyakanthan Jeyaraman, Richard Mariadasse, et al.
Archives of Biochemistry and Biophysics|September 26, 2024
Harnessing marine natural products to inhibit PAD4 triple mutant: A structure-based virtual screening approach for rheumatoid arthritis therapySanthiya Panchalingam, Manikandan Jayaraman, Jeyakanthan Jeyaraman, et al.
Computational Biology and Chemistry|December 12, 2023
Computational insights into potential marine natural products as selective inhibitors of Mycobacterium tuberculosis InhA: A structure-based virtual screening studyManikandan Jayaraman, Vijayakumar Gosu, Rajalakshmi Kumar, et al.
Computers in Biology and Medicine|January 17, 2026
Machine learning guided structural dynamics identifies translation elongation factor 1 (EEF1A1) as an immunological biomarker and marine natural products as therapeutic leads for rheumatoid arthritis with major depressive disorderSanthiya Panchalingam, Govindaraju Kasivelu, Manikandan Jayaraman, et al.
Computational Biology and Chemistry|April 14, 2024
Mechanistic insights into the conformational changes and alterations in residual communications due to the mutations in the pncA Gene of Mycobacterium tuberculosis: A computational perspective for effective therapeutic solutionsManikandan Jayaraman, Rajalakshmi Kumar, Santhiya Panchalingam, et al.
Computational Biology and Chemistry|September 6, 2023
Multilayer precision-based screening of potential inhibitors targeting Mycobacterium tuberculosis acetate kinase using in silico approachesSneha Subramaniyan, Hemavathy Nagarajan, Umashankar Vetrivel, et al.
Pageof 6